Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,702,846,909
+$128,506,442 QoQ
Shares Held
30,075,134
+6.4% QoQ
Ownership
1.94%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#5
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. AZN ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,702,846,909 | 30,075,134 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,574,340,467 | 28,264,580 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||